{
    "clinical_study": {
        "@rank": "122684", 
        "acronym": "PRO-BRA", 
        "arm_group": {
            "arm_group_label": "TiLOOP Bra", 
            "arm_group_type": "Other", 
            "description": "Treatment with TiLOOP Bra"
        }, 
        "brief_summary": {
            "textblock": "This multicentre, non-randomised, observational clinical device investigation will be\n      performed to obtain postmarketing information on the TiLOOP\u00ae Bra and in particular on the\n      improvement of the patients' quality of life as well as on the rate of complications of the\n      device under investigation.\n\n      The objective of this clinical investigation is to establish the feasibility, efficacy and\n      safety of the TiLOOP\u00ae Bra."
        }, 
        "brief_title": "National, Multicenter PMS Study \"Patient Reported Outcome\" in Breast Reconstruction Following Mastectomy With TiLOOP Bra", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Reconstruction After Mastectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        The TiLOOP\u00aeBra is designed to assist oncologically indexed skin sparing mastectomy or\n        subcutaneous mastectomy with preservation of the nipple-areola-complex during primary\n        breast reconstruction, secondary breast reconstruction or corrective breast surgery.\n        Patients shall be included if they meet all of the following criteria:\n\n        Clinical Criteria (reason):\n\n          -  women with indication of prophylactic operation or oncoplastic operation with support\n             of a mesh implant\n\n          -  women with histologically confirmed breast cancer or precancerosis or genetic\n             pre-existing conditions with increased risk of breast cancer or with a family history\n\n          -  the health of women must comply with ECOG (Eastern Cooperative Oncology Group)\n             performance status 0-2\n\n        Study-related inclusion criteria - Legal reasons:\n\n          -  Patient is mentally able to understand the nature, aims, or possible consequences of\n             the clinical investigation\n\n          -  Patient information has been handed out and all written consents are at hand.\n\n          -  Patient is between 18 and 75 years old.\n\n        Exclusion Criteria:\n\n        Patients must be excluded if any of the following conditions exist or cannot be excluded:\n\n        Device-related exclusion criteria (contraindications):\n\n        Pathological or physical condition precluding such as:\n\n          -  Pregnancy or breast-feeding patients\n\n          -  Known intolerance to the mesh-implants under investigation.\n\n        Study-related exclusion criteria - Medical reasons:\n\n          -  metastatic breast cancer\n\n          -  medicamentous regulated diabetes with blood sugar level >250\n\n          -  inadequate bone marrow function with neutrophil granulocytes  <1500 and blood plates\n             < 10000/\u00b5l\n\n          -  patient with known contraindication to mesh-implants or plastic-reconstructive breast\n             operations\n\n        Study-related exclusion criteria - Legal reasons:\n\n          -  Lack of written patients informed consent.\n\n          -  Lack of patient compliance regarding data collection, treatment or follow-up\n             investigations in the scope of the protocol.\n\n          -  Patient is institutionalized by court or official order (MPG\u00a720.3).\n\n          -  Participation in another operative clinical investigation.\n\n        It is thought that the study-related exclusion criteria will not significantly influence\n        the sample of the population under investigation."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "260", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885572", 
            "org_study_id": "pfm 12k001 TiLOOP Bra"
        }, 
        "intervention": {
            "arm_group_label": "TiLOOP Bra", 
            "description": "Titaniferously coated polypropylene mesh", 
            "intervention_name": "TiLOOP Bra", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "breast reconstruction", 
            "mastectomy", 
            "mesh", 
            "breast cancer"
        ], 
        "lastchanged_date": "January 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13125"
                    }, 
                    "name": "Helios Kliniken"
                }, 
                "investigator": {
                    "last_name": "Christine Mau, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10967"
                    }, 
                    "name": "Vivantes Kliniken am Urban"
                }, 
                "investigator": {
                    "last_name": "Andree Faridi, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10713"
                    }, 
                    "name": "St. Gertrauden Krankenhaus"
                }, 
                "investigator": {
                    "last_name": "Jens-Uwe Blohmer, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt am Main", 
                        "country": "Germany", 
                        "zip": "60431"
                    }, 
                    "name": "Agaplesion Markus Krankenhaus"
                }, 
                "investigator": {
                    "last_name": "Marc Thill, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Koeln", 
                        "country": "Germany", 
                        "zip": "50935"
                    }, 
                    "name": "St. Elisabeth Krankenhaus"
                }, 
                "investigator": {
                    "last_name": "Anette Meire, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muenchen", 
                        "country": "Germany", 
                        "zip": "81675"
                    }, 
                    "name": "Technische Universit\u00e4t"
                }, 
                "investigator": {
                    "last_name": "Stefan Paepke, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rostock", 
                        "country": "Germany", 
                        "zip": "18057"
                    }, 
                    "name": "Universit\u00e4tsfrauenklinik"
                }, 
                "investigator": {
                    "last_name": "Max Dieterich, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "National, Multicenter Post-market Surveillance Study \"Patient Reported Outcome\" in Breast Reconstruction Following Mastectomy With Titaniferously Coated Polypropylene Mesh (TiLOOP Bra)", 
        "overall_contact": {
            "email": "sabrina.tofall@pfmmedical.com", 
            "last_name": "Sabrina Tofall"
        }, 
        "overall_official": {
            "affiliation": "Technical University Munich, Ismaningerstrasse 22, 81675 Munich, Germany", 
            "last_name": "Stefan Paepke, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of the Patient Reported Outcome (PRO).", 
            "measure": "PRO", 
            "safety_issue": "No", 
            "time_frame": "12 months after breast reconstruction"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885572"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of the Patient Reported Outcome", 
                "measure": "PRO", 
                "safety_issue": "No", 
                "time_frame": "6 and 24 months after breast reconstruction"
            }, 
            {
                "description": "Complication rate of the first 60 patients in the 6 month follow-up and of all patients after 6, 12 and 24 months.", 
                "measure": "Complication Rate", 
                "safety_issue": "Yes", 
                "time_frame": "after 6, 12 and 24 months"
            }, 
            {
                "description": "Cosmetic success confirming the reinforcement will be assessed by the patient and an independent professional at a photo. The questions posed are part of the validated Breast Q questionnaire.", 
                "measure": "Cosmetic Success", 
                "safety_issue": "No", 
                "time_frame": "6, 12 and 24 months after breast reconstruction"
            }
        ], 
        "source": "Pfm Medical Mepro Gmbh", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "pfm medical ag", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "pfm medical titanium gmbh", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Pfm Medical Mepro Gmbh", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}